Shenzhen Xintai Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
The 19th meeting of the 6th Board of Directors of Shenzhen Xintai Pharmaceutical Co., Ltd. was held in writing on May 29, 2026, with the meeting notice delivered via email on May 28, 2026. All directors unanimously agreed to waive the notice period for this board meeting. A total of 9 directors were supposed to participate, and all 9 participated in writing, meeting the legal quorum. The convening of this meeting complies with relevant laws, regulations, and the Company’s Articles of Association. The attending directors reviewed and formed the following resolutions: